Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $3.98 billion
- Book Value:
- Revenue TTM:
- $4.54 billion
- Operating Margin TTM:
- Gross Profit TTM:
- $2.55 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Ambu A/S had its IPO on under the ticker symbol AMBBY.
The company operates in the Healthcare sector and Medical Devices industry. Ambu A/S has a staff strength of 4,500 employees.
Shares of Ambu A/S opened at $14.76 at the start of the last trading session i.e. 2023-03-21.
The stocks traded within a range of $14.76 - $14.76, and closed at $14.76.
This is a -1.27% slip from the previous day's closing price.
A total volume of 100 shares were traded at the close of the day’s session.
In the last one week, shares of Ambu A/S have slipped by -3.97%.
Ambu A/S's Key Ratios
Ambu A/S has a market cap of $3.98 billion, indicating a price to book ratio of 5.8523 and a price to sales ratio of 0.7638.
In the last 12-months Ambu A/S’s revenue was $4.54 billion with a gross profit of $2.55 billion and an EBITDA of $307 million. The EBITDA ratio measures Ambu A/S's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Ambu A/S’s operating margin was 3.3% while its return on assets stood at 1.41% with a return of equity of 2.36%.
In Q4, Ambu A/S’s quarterly earnings growth was a positive 12.5% while revenue growth was a positive 9.8%.
Ambu A/S’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.05 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ambu A/S’s profitability.
Ambu A/S stock is trading at a EV to sales ratio of 0.8402 and a EV to EBITDA ratio of 7.5887. Its price to sales ratio in the trailing 12-months stood at 0.7638.
Ambu A/S stock pays annual dividends of $0 per share, indicating a yield of 0.32% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $7.01 billion
- Total Liabilities
- $996.00 million
- Operating Cash Flow
- Capital Expenditure
- $76 million
- Dividend Payout Ratio
Ambu A/S ended 2023 with $7.01 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $7.01 billion while shareholder equity stood at $4.12 billion.
Ambu A/S ended 2023 with $0 in deferred long-term liabilities, $996.00 million in other current liabilities, 129000000.00 in common stock, $3.78 billion in retained earnings and $1.56 billion in goodwill. Its cash balance stood at $125.00 million and cash and short-term investments were $125.00 million. The company’s total short-term debt was $82,000,000 while long-term debt stood at $1.38 billion.
Ambu A/S’s total current assets stands at $2.22 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $709.00 million compared to accounts payable of $509.00 million and inventory worth $1.21 billion.
In 2023, Ambu A/S's operating cash flow was $0 while its capital expenditure stood at $76 million.
Comparatively, Ambu A/S paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Ambu A/S stock is currently trading at $14.76 per share. It touched a 52-week high of $18.01 and a 52-week low of $18.01. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $14.83 and 200-day moving average was $11.81 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Ambu A/S
Similar Industry Stocks (Medical Devices)
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.